Mazumdar-Shaw Kiran
SEC insider (Form 3/4/5 filer). CIK 0002034672. Director at Bicara Therapeutics Inc. (BCAX). 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in BOSTON, MA.
Companies Mazumdar-Shaw Kiran has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Director
Mazumdar-Shaw Kiran
CIK: 0002034672
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bicara Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 9, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
19.5K shares- - Jun 9, 2025BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
23.7K shares- - Sep 16, 2024BCAX
Bicara Therapeutics Inc.
ConversionIndirect324.6K shares- - Sep 16, 2024BCAX
Bicara Therapeutics Inc.
ConversionIndirect4.3M shares- - Sep 16, 2024BCAX
Bicara Therapeutics Inc.
ConversionIndirect432.7K shares- - Sep 16, 2024BCAX
Bicara Therapeutics Inc.
ConversionIndirect1.1M shares- - Sep 12, 2024BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
23.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 19,475 | - | - | Direct |
| Jun 9, 2025 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 23,746 | - | - | Direct |
| Sep 16, 2024 | BCAX Bicara Therapeutics Inc. | Conversion | 324,552 | - | $0 | Indirect |
| Sep 16, 2024 | BCAX Bicara Therapeutics Inc. | Conversion | 4,327,365 | - | $0 | Indirect |
| Sep 16, 2024 | BCAX Bicara Therapeutics Inc. | Conversion | 432,736 | - | $0 | Indirect |
| Sep 16, 2024 | BCAX Bicara Therapeutics Inc. | Conversion | 1,080,775 | - | $0 | Indirect |
| Sep 12, 2024 | BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 23,746 | - | - | Direct |
1-7 of 7 transactions